Telix Pharmaceuticals has resubmitted its FDA application for TLX101-Px, a new brain cancer imaging candidate. The post Telix Pharmaceuticals resubmits FDA application for brain cancer imaging agent ...
Some hospitals in the Netherlands are paying up to €2,800 more than others for the same cancer medicines, according to research examining how oncology drugs are priced across European ...
MyChesCo on MSN
FDA moves to cut costs for biosimilar drug development
WASHINGTON, D.C. — The U.S. Food and Drug Administration announced new draft guidance aimed at reducing the cost and complexity of developing biosimilar medicines, a move the agency says could ...
Hospitals in the Netherlands are paying vastly different amounts for the same cancer medications, with some treatments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results